The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2020
Filed:
Jun. 20, 2014
Applicant:
Glenmark Pharmaceuticals S.a., La Chaux-de-Fonds, CH;
Inventors:
Ulhas Rameshchandra Dhuppad, Nashik, IN;
Sunil Sudhakar Chaudhari, Nashik, IN;
Suresh Mahadev Rajurkar, Nashik, IN;
Nilesh Jayantilal Jain, Nashik, IN;
Assignee:
Glenmark Pharmaceuticals S.A., La Chaux-de-Fonds, CH;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 9/51 (2006.01); A61K 31/519 (2006.01); A61K 9/20 (2006.01);
U.S. Cl.
CPC ...
A61K 9/14 (2013.01); A61K 9/1676 (2013.01); A61K 9/5123 (2013.01); A61K 9/5138 (2013.01); A61K 9/5146 (2013.01); A61K 9/5192 (2013.01); A61K 31/519 (2013.01); A61K 9/2081 (2013.01);
Abstract
The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin-1 receptor ('TRPA1') antagonist. Particularly, the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer; a process for preparing such formulation; and its use in treating a respiratory disorder or pain in a subject.